News and Trends 30 Jun 2023 FDA approves BioMarin gene therapy for hemophilia A BioMarin Pharmaceutical Inc. has announced that the United States Food and Drug Administration (FDA) has approved ROCTAVIAN (valoctocogene roxaparvovec-rvox) gene therapy for the treatment of adults with severe hemophilia A… June 30, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 31 Aug 2022 Gel treatment for erectile dysfunction receives positive results from clinical trial …Subjects were recruited from United States (African Americans), Poland, Georgia and Bulgaria and included men who had organic and psychological ED or a combination of both. Ken James, executive director… August 31, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
More News! 10 Oct 2022 RadioMedix announces a $40 million series A financing for targeted alpha therapy platform …developed by Dr. Delpassand and his team should significantly impact cancer treatments globally. Portland and RadioMedix have aligned their complementary capabilities and are united by a commitment to help others.”… October 10, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2024 Will the US biotech funding surge trigger a renaissance in the global biotech industry? In recent months, the United States has witnessed a remarkable resurgence in biotech investments, marking a significant turnaround from the preceding challenges faced by the sector. This revival is characterized… March 18, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2025 Top biotech deals in September 2025 …developer Enlaza Therapeutics have united to develop T-cell engagers as well as a new type of therapy called war-lock drug conjugates, a term coined by Enlaza. These drugs differ from… October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2025 Why are there only 20 cell and gene therapies in Europe? …pointed out that reports by the Alliance for Regenerative Medicine highlight a stark funding disparity between Europe and the United States for cell and gene therapy (CGT) companies. “Despite Europe… January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Opinion 28 Feb 2023 Life changing treatments for rare disease – a beacon of hope …1983 in the United States, which revolutionized the industry overnight. This legislation was brought in following recent medical advances to deliberately incentivize the pharmaceutical industry to invest in the development… February 28, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 21 Dec 2022 Poolbeg identifies new potential drug candidates for RSV infections …past few months, RSV has been sending children to hospital at alarming rates in the United States and Europe. As pediatric units fill beyond capacity, and our healthcare systems contend… December 21, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2016 This has been the Worst Financial Year for Biotech in a Decade A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate has done some damage. There’s a political storm brewing across… November 10, 2016 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2022 Financing round of $21M completed for drug to treat autoimmune diseases …rights of CID-103 in autoimmune indications in the United States. CASI also has the co-commercial rights in the autoimmune-derived hematology indications for CID-103 in China, but is not obligated to co-commercialize those… July 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Promising drug candidate discovered for prevention of type 1 diabetes …TYK2 inhibitor. This drug molecule has already been approved in the United States for the treatment of psoriasis,” Otonkoski notes. According to Otonkoski, the effect of TYK2 inhibitors in the… November 10, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Mar 2025 Seven biotech companies keeping Taiwan dynamic in 2025 …precision medicine, immunotherapy, and drug development. While Taiwan does not compete with global biotech behemoths like the United States or Europe, it benefits from government support and a growing research… March 5, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email